Renaissance Technologies - ACHILLES THERAPEUTICS PLC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ACHILLES THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$398
-6.4%
437,528
-2.7%
0.00%0.0%
Q2 2023$425
+16.8%
449,733
+18.3%
0.00%
Q1 2023$364
-16.5%
380,233
-21.6%
0.00%
-100.0%
Q4 2022$436
-99.8%
484,733
+498.2%
0.00%
Q3 2022$183,000
-16.8%
81,033
-7.1%
0.00%
Q2 2022$220,000
+144.4%
87,233
+185.7%
0.00%
Q1 2022$90,000
-29.7%
30,533
+19.6%
0.00%
Q4 2021$128,00025,5330.00%
Other shareholders
ACHILLES THERAPEUTICS PLC shareholders Q4 2023
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 11,086,909$55,545,00053.06%
RA Capital Management 5,014,687$25,124,0000.44%
Artal Group S.A. 2,255,375$11,299,0000.31%
Redmile Group, LLC 2,088,089$10,461,0000.24%
Orbimed Advisors 1,584,845$7,940,0000.10%
Sender Co & Partners, Inc. 27,690$139,0000.07%
Baker Brothers Advisors 2,591,366$12,983,0000.06%
Perceptive Advisors 1,510,750$7,568,0000.06%
Woodline Partners LP 324,387$1,625,0000.02%
Point72 Asset Management, L.P. 1,000,000$5,010,0000.02%
View complete list of ACHILLES THERAPEUTICS PLC shareholders